Estrogen receptor-mediated cross-talk with growth factor signaling pathways
Tóm tắt
Estrogen (E2) palys critical roles in the development of tumors in female reproductive organs. Development of most breast cancers is dependent on E2 in most cases. Most E2 actions are considered to be exerted through two subtypes of Estrogen receptors (ERs), ER α and ER β. ERs belong to the nuclear receptor superfamily, and act as ligand-inducible transcription factors to activate transcription of a particular set of the target genes. Ligand-bound ER recruits at least two distinct classes of coactivator complexes. In estrogen-dependent breast cancer, growth factors are shown to often act synergisticaly with E2, and the breast cancer often become resistant to treatment of estogen antagonists. However, the molecular basis of this coupled regulation of growth factor- and ER-mediated signaling and hormone-resistance are largely unknown. We have previously shown that MAP (mitogen-activated protein) kinase (MAPK) activated by growth factors phosphorylates and potentiates the N-terminal transactivation function (AF-1), indicating a possible molecular mechanism of a novel cross-talk between two signalings (Katoet al, 1995). Furthermore, we have identified a coactivator that specifically interacts with ER α AF-1 (Endohet al, 1999). In this review, this cross-talk is discussed in terms of the transactivation function of ERs and their coactivators.
Tài liệu tham khảo
Ali S, Metzger D, Bornert M,et al: Modulation of transcriptional activation by Ligand-dependent phosphorylation of the human estron receptor A/B region.EMBO J. 12:1153–1160, 1993.
Arnold F, Obourn D, Yudt R,et al: In vivo and in vitro phosphorylation of the human estrogen receptor.J Steroid Biochem Mol Biol. 52:159–171, 1995.
Brozozowski M, Pike C, Dauter Z,et al: Molecular basis of agonism and antagonism in the estrogen receptor.Nature 389:753–758, 1997.
Byers M, Kuiper M, Gustafsson A,et al: Estrogen receptor-b mRNA expression in rat ovary: down-regulation by gonadotropins.Mol. End. 11:172–182, 1997.
Chen D, Evans R: A transcriptional co-repressor that interacts with nuclear hormone receptors.Nature 377:454–457, 1995.
Chen H, Lin R, Schiltz R,et al: Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300.Cell 90:569–580, 1997.
Couse J, Curtis S, Bunch D,et al: Postnatal sex reversal of the ovaries in mice lacking estrogen receptors a and b.Science 286:2328–2331, 1999.
Eddy M, Washburn F, Buncho 0,et al: Targeted disruption of the estrogen receptor gene in male mice causes alteration of spermatogenesis and infertility.Endocrinology 137:4796–805, 1996.
Eisen A, Lucchesi J: Unraveling the role of helicases in transcription.BioEssays 20:634–641, 1998.
Endoh H, Maruyama K, Masuhiro Y,et al: Purification and identification of p68 RNA helicase acting as a transcriptional coactivator specific for the activation function 1 of human estrogen receptor α.Mol. Cell. Biol. 19:5363–5372, 1999.
Evans M: The steroid and thyroid hormone receptor superfamily.Science 240:889–895, 1988.
Fuse H, Kitagawa H, Kato S: Characterization of transactivational property and coactivator mediation of rat mineralocorticoid receptor AF-1.Mol. Endocrinol., 14:889–899, 2000.
Fondell D, Ge H, Roeder R: Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex.Proc. Natl. Acad. Sci. 93:8329–8333, 1996.
Freedman P: Increasing the complexity of coactivation in nuclear receptor signaling.Cell 97:5–8, 1999.
Glass C, Rosenfeld M: The coregulator exchange in transcriptional functions of nuclear receptors.Genes & Dev. 14:121–141, 2000.
Gonzalez A, Raden L, Davis J: Identification of substrate recognition determinants for human ERK1 and ERK2 protein kinases.J Biol Chem. 266:22159–22163, 1991.
Green S, Chambon P: Nuclear receptors enhance our understanding of transcription regulation.Trends Genet. 4:309–314, 1988.
Gronemeyer H: Transcription activation by estrogen and progesterone receptors.Annu Rev Genet. 25:89–123, 1991.
Gullick J: Growth factors and oncogenes in breast cancer.Prog Growth Factor Res. 2:1–13, 1990.
Hamm J, Lamond A: The unwinding role of DEAD-box proteins.Curr. Bio. 8:532–534, 1998.
Heery M, Kalkhoven E, Hoare S,et al: A signature motif in transcriptional co-activators mediates binding to nuclear receptors.Nature 387:733–736, 1997.
Horlein J, Naar A, Heinzel T,et al: Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor corepressor.Nature 377:397–404, 1995.
Hu X, Lazar M: The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors.Nature 402:93–96, 1999.
Inoue S, Orimo A, Hosoi T,et al: Genomic binding-site cloning reveals an estrogen-responsive gene that encodes a RING finger protein.Proc. Natl. Acad. Sci. 90:11117–11121, 1993.
Joel B, Traish M, Lannigan A: Estradiol and phorbol ester cause phosphorylation of serine 118 in the human estrogen receptor.Mol Endocrinol. 9:1041–1052, 1995.
Kalkhoven E, Valentine J, Herry D,et al: Isoforms of steroid receptor co-activator 1 differ in their ability to potentiate transcription by the estrogen receptor.EMBO J. 17:232–243, 1998.
Kamei Y, Xu L, Heinzel T,et al: A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors.Cell 85:403–414, 1996.
Kato S, Tora L, Yamauchi J,et al: A far upstream estrogen response element of the ovalbumin gene contains several half-palindromic 5’-TGACC-3’ motifs acting synergistically.Cell 68:731–742, 1992.
Kato S, Endoh H, Masuhiro Y,et al: Activation of the estrogen receptor through phosphorylation by mitogen-activated protein-kinase.Science 270:1491–1494, 1995.
Knoepfler P, Eisenman R: Sin meets NuRD and other tails of repression.Cell. 99:447–450, 1999.
Kobayashi Y, Kitamoto T, Masuhiro Y,et al: p300 mediates functional synergism between AF-1 and AF-2 of estrogen receptor α and β by interacting directly with the N-terminal A/B domains.J Biol Chem. 275:15645–15651, 2000.
Korach K. S: Insights from the study of Animals lacking functional estrogen receptor.Science 266:1524–1527, 1994.
Krege H, Hodgin B, Couse F,et al: Generation and reproductive phenotypes of mice lacking estrogen receptor.Proc. Natl. Acad. Sci. 95:15677–15682, 1998.
Kuiper G, Enmark E, Pelto-Huikko M,et al: Cloning of a novel receptor expressed in rat prostate and ovary.Proc Natl Acad Sci USA 93:5925–5930, 1996.
Lanz B, McKenna J, Onate A,et al: A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex.Cell 97:17–27, 1999.
Mangelsdorf J, Thummel C, Beato M,et al: The nuclear receptor superfamily: the second decade.Cell 83:835–839, 1995.
Martinez E, Wahli W: Cooperative binding of estrogen receptor in imperfect estrogen-responsive DNA elements correlates with their synergistic hormone-dependent enhancer activity.EMBO J. 8:3781–3791, 1989.
Murphy C, Dotzalaw H, Wong S,et al: Epidermal growth factor: receptor and ligand expression in human breast cancer.Semin Cancer Biol. 1:305–315, 1991.
Nagpal S, Friant S, Nakshatri H,et al: RARs and RXRs: evidence for two autonomous transactivation functions (AF-1 and AF-2) and heterodimerizatio.in vivo.EMBO J. 12:2349–2360, 1993.
Nuclear receptors nomenclature committee: A unified nomenclature system for the nuclear receptor superfamily.Cell 97:161–163, 1999.
Onate A, Tsai Y, Tsai J,et al: Sequence and characterization of a coactivator for the steroid hormone receptor superfamily.Science 270:1354–1357, 1995.
Parker G: Steroid and related receptors.Curr. Opin. Cell Biol. 5:499–504, 1993.
Pettersson K, Grandien K, Kuiper M,et al: Mouse estrogen receptor forms estrogen response element binding heterodimers with estrogen receptor.Mol. End. 11:1486–1496, 1997.
Rachez C, Lemon D, Suldan Z,et al: Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex.Nature 398:824–828, 1999.
Shiau A, Barstad D, Loria P,et al: The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen.Cell 95:927–937, 1998.
Spencer E, Jenster G, Burcin M,et al: W Steroid receptor coactivator-1 is a histone acetyltransferase.Nature 389:194–198, 1997.
Tasset D, Tora L, Fromental C,et al: Distinct classes of transcriptional activating domains function by different mechanisms.Cell 62:1177–1187, 1990.
Tora L, White J, Brou C,et al: The human estrogen receptor has two independent non-acidic transcriptional activation functions.Cell 59:477–487, 1989.
Tremblay A, Tremblay B, Labrie F,et al: Ligand-independent recruitment of SRC-1 to estrogen receptor beta through phosphorylation of activation function AF-1.Mol. Cell 3:513–519, 1999.
Tsuji J, Kishimoto K, Hiyama A,et al: The Kinase TAK1 can activate the NIK-IkB as well as the MAP kinase cascade in the IL-1 signaling pathway.Nature 398:252–256, 1999.
Voegel J, Heine M, Zechel C,et al: TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors.EMBO J. 15, 3667–3675, 1996.
Voegel J, Heine M, Zechel C,et al: TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors.EMBO J. 15:3667–3675, 1996.
Wade A, Wolffe P: Transcriptional regulation: Switching circuitry.Curr. Bio. 9:221–224, 1999.
Watanabe M, Yanagisawa J, Kitagawa H,et al: A Subfamily of RNA binding DEAD-box proteins acts as an estrogen receptor α-AF-1 coactivator with a RNA coactivator, SRA. (submitted)
Wurtz M, Bourguet W, Renaud P,et al: A canonical structure for the ligand-binding domain of nuclear receptors.Nature Structural Biology 3:87–94, 1996.
Yanagisawa J, Yanagi, Masuhiro Y,et al: Convergence of TGFb and vitamin D signaling pathways on SMAD proteins acting as common transcriptional co-activators.Science 283:1317–1321, 1999.